Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma
2025 · Cell Death and Disease · 9 citations
https://doi.org/10.1038/s41419-025-07789-5
A
Aomei Ling
Tianjin Medical University Cancer Institute and Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
16
Citations
2
h-index
0
i10-index
Aomei Ling is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Wnt/β-catenin signaling in development and cancer & Liver physiology and pathology. The author has an h-index of 2, co-authored 3 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat